Tirabosco R, O’Donnell P, Yamaguchi T (2020) Conventional chordoma. WHO classification of Tumours of Soft tissue and bone, 5th edn. Agency for Research on Cancer
Chauvel A, Taillat F, Gille O et al (2005) Giant vertebral notochordal rest: a new entity distinct from chordoma. Histopathology 47(6):646–649. https://doi.org/10.1111/j.1365-2559.2005.02168.x
Article CAS PubMed Google Scholar
Pan Y, Lu L, Chen J, Zhong Y, Dai Z (2018) Analysis of prognostic factors for survival in patients with primary spinal chordoma using the SEER Registry from 1973 to 2014. J Orthop Surg Res 13(1):76. https://doi.org/10.1186/s13018-018-0784-3
Article PubMed PubMed Central Google Scholar
Tirabosco R, Mangham DC, Rosenberg AE et al (2008) Brachyury expression in extra-axial skeletal and soft tissue chordomas: a marker that distinguishes chordoma from mixed tumor/myoepithelioma/parachordoma in soft tissue. Am J Surg Pathol 32(4):572–580. https://doi.org/10.1097/PAS.0b013e31815b693a
Carter JM, Wenger DE, Rose PS, Inwards CY (2017) Atypical notochordal cell tumors: a Series of Notochordal-derived tumors that defy current classification schemes. Am J Surg Pathol 41(1):39–48. https://doi.org/10.1097/PAS.0000000000000766
Yamaguchi T, Imada H, Iida S, Szuhai K (2017) Notochordal tumors. Surg Pathol Clin 10(3):637–656. https://doi.org/10.1016/j.path.2017.04.008
Arain A, Hornicek FJ, Schwab JH, Chebib I, Damron TA (2017) Chordoma arising from benign multifocal notochordal tumors. Skeletal Radiol 46(12):1745–1752. https://doi.org/10.1007/s00256-017-2727-1
Kreshak J, Larousserie F, Picci P et al (2014) Difficulty distinguishing benign notochordal cell tumor from chordoma further suggests a link between them. Cancer Imaging 14(1):4. https://doi.org/10.1186/1470-7330-14-4
Article PubMed PubMed Central Google Scholar
Lauer SR, Edgar MA, Gardner JM, Sebastian A, Weiss SW (2013) Soft tissue chordomas: a clinicopathologic analysis of 11 cases. Am J Surg Pathol 37(5):719–726. https://doi.org/10.1097/PAS.0b013e31827813e7
Kikuchi Y, Yamaguchi T, Kishi H et al (2011) Pulmonary tumor with notochordal differentiation: report of 2 cases suggestive of benign notochordal cell tumor of extraosseous origin. Am J Surg Pathol 35(8):1158–1164. https://doi.org/10.1097/PAS.0b013e318220e085
Tateda S, Hashimoto K, Aizawa T et al (2018) Diagnosis of benign notochordal cell tumor of the spine: is a biopsy necessary? Clin Case Rep 6(1):63–67. https://doi.org/10.1002/ccr3.1287
Terzi S, Mobarec S, Bandiera S et al (2012) Diagnosis and treatment of benign notochordal cell tumors of the spine: report of 3 cases and literature review. Spine (Phila Pa 1976) 37(21):E1356–1360. https://doi.org/10.1097/BRS.0b013e318266e7e6
Martínez Gamarra C, Bernabéu Taboada D, Pozo Kreilinger JJ, Tapia Viñé M (2018) Benign notochordal cell tumors. Radiologia (Engl Ed) 60(2):167–170. https://doi.org/10.1016/j.rx.2017.06.008
Murphey MD, Minn MJ, Contreras AL et al (2023) Imaging of spinal chordoma and benign notochordal cell tumor (BNCT) with radiologic pathologic correlation. Skeletal Radiol 52(3):349–363. https://doi.org/10.1007/s00256-022-04158-7
Erazo IS, Galvis CF, Aguirre LE, Iglesias R, Abarca LC (2018) Clival Chondroid Chordoma: a Case Report and Review of the literature. Cureus Published Online September 28. https://doi.org/10.7759/cureus.3381
Deshpande V, Nielsen GP, Rosenthal DI, Rosenberg AE (2007) Intraosseous benign notochord cell tumors (BNCT): further evidence supporting a relationship to chordoma. Am J Surg Pathol 31(10):1573–1577. https://doi.org/10.1097/PAS.0b013e31805c9967
Rosenberg AE, Bhan AK, Lee JM (1995) Chondroid chordoma. Am J Clin Pathol 104(4):484. https://doi.org/10.1093/ajcp/104.4.484a
Article CAS PubMed Google Scholar
Vujovic S, Henderson S, Presneau N et al (2006) Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas. J Pathol 209(2):157–165. https://doi.org/10.1002/path.1969
Article CAS PubMed Google Scholar
Presneau N, Shalaby A, Ye H et al (2011) Role of the transcription factor T (brachyury) in the pathogenesis of sporadic chordoma: a genetic and functional-based study. J Pathol 223(3):327–335. https://doi.org/10.1002/path.2816
Article CAS PubMed Google Scholar
Barresi V, Ieni A, Branca G, Tuccari G, Brachyury (2014) A diagnostic marker for the Differential diagnosis of Chordoma and Hemangioblastoma versus neoplastic histological mimickers. Dis Markers 2014:1–7. https://doi.org/10.1155/2014/514753
Court C, Briand S, Mir O et al (2022) Management of chordoma of the sacrum and mobile spine. Orthop Traumatol Surg Res 108(1S):103169. https://doi.org/10.1016/j.otsr.2021.103169
Bederman SS, Shah KN, Hassan JM, Hoang BH, Kiester PD, Bhatia NN (2014) Surgical techniques for spinopelvic reconstruction following total sacrectomy: a systematic review. Eur Spine J 23(2):305–319. https://doi.org/10.1007/s00586-013-3075-z
Akinduro OO, Suarez-Meade P, Garcia D et al (2021) Targeted therapy for Chordoma: Key Molecular Signaling pathways and the role of Multimodal Therapy. Targ Oncol 16(3):325–337. https://doi.org/10.1007/s11523-021-00814-5
Chhabra AM, Rice SR, Holtzman A et al (2023) Clinical outcomes and toxicities of 100 patients treated with proton therapy for chordoma on the Proton collaborative group prospective registry. Radiother Oncol 183:109551. https://doi.org/10.1016/j.radonc.2023.109551
Article CAS PubMed Google Scholar
Meng T, Jin J, Jiang C et al (2019) Molecular targeted therapy in the treatment of Chordoma: a systematic review. Front Oncol 9:30. https://doi.org/10.3389/fonc.2019.00030
Article PubMed PubMed Central Google Scholar
Kurup AN, Woodrum DA, Morris JM et al (2012) Cryoablation of Recurrent Sacrococcygeal tumors. J Vasc Interv Radiol 23(8):1070–1075. https://doi.org/10.1016/j.jvir.2012.05.043
Lee IJ, Lee RJ, Fahim DK (2017) Prognostic factors and survival outcome in patients with Chordoma in the United States: a Population-based analysis. World Neurosurg 104:346–355. https://doi.org/10.1016/j.wneu.2017.04.118
Huang Z, Fan Z, Zhao C, Sun H (2021) A Novel Nomogram for Predicting Cancer-specific survival in patients with spinal chordoma: a Population-based analysis. Technol Cancer Res Treat 20:153303382110365. https://doi.org/10.1177/15330338211036533
留言 (0)